What is the appropriate acute treatment for a patient with severe pain in the left ankle, foot, and big toe, serum uric acid 11.3 mg/dL, and normal kidney function?

Acute Gout Treatment

For this patient with severe pain in the left ankle, foot, and big toe with markedly elevated uric acid (11.3 mg/dL) and normal kidney function, immediately treat the acute flare with corticosteroids as first-line therapy, NSAIDs as an alternative, or low-dose colchicine if the others are contraindicated—do NOT start urate-lowering therapy yet. 1

Immediate Management of the Acute Flare

The clinical presentation (severe pain in ankle, foot, and big toe with hyperuricemia of 11.3 mg/dL) is highly consistent with acute gout. The priority is rapid pain control through anti-inflammatory treatment.

First-Line Options (Choose One):

Corticosteroids (Preferred):

• Prednisolone 35 mg daily for 5 days 1
• Most effective anti-inflammatory option with fewer adverse effects than NSAIDs
• Safest and lowest cost option when not contraindicated
• Contraindicated only in systemic fungal infections

NSAIDs (Alternative):

• Any NSAID at maximal dose (no evidence that indomethacin is superior to naproxen or ibuprofen) 1
• Avoid if patient has renal disease, heart failure, or cirrhosis
• Consider PPI co-prescription for GI protection

Low-Dose Colchicine (Third Option):

• 1.2 mg followed by 0.6 mg one hour later 1
• This low-dose regimen is as effective as high-dose but with significantly fewer GI side effects
• More expensive than corticosteroids or NSAIDs
• Contraindicated with concurrent use of strong CYP3A4 or P-glycoprotein inhibitors

Critical Timing

Start treatment within hours of symptom onset for maximum effectiveness 2. The longer you wait, the less effective any anti-inflammatory agent becomes.

What NOT to Do During the Acute Flare

Do not start urate-lowering therapy (allopurinol, febuxostat) during this first attack. 1 The 2017 ACP guidelines strongly recommend against initiating long-term urate-lowering therapy after a first gout attack or in patients with infrequent attacks (<2 per year).

While the 2020 ACR guideline 3 conditionally supports starting ULT during a flare if the decision has already been made that ULT is indicated, this patient is presenting with what appears to be a first or early attack—ULT is not yet indicated.

After the Acute Flare Resolves

When to Consider Urate-Lowering Therapy:

Only initiate ULT if the patient experiences:

• ≥2 gout attacks per year, OR
• Presence of tophi, OR
• Chronic kidney disease, OR
• Urolithiasis

1

If ULT Becomes Indicated:

1. Start prophylaxis first: Low-dose colchicine or NSAID for 3-6 months before or concurrent with ULT initiation 3
2. Begin allopurinol: Start low (100 mg daily) and titrate up to achieve serum uric acid <6.0 mg/dL
3. Continue prophylaxis: For at least 3-6 months to prevent flares triggered by urate mobilization 3

Common Pitfalls to Avoid

• Don't check serum uric acid during the acute attack for diagnostic purposes—levels often drop during flares and can be misleadingly normal 4, 5
• Don't use high-dose colchicine—the traditional 0.6 mg every hour regimen causes severe diarrhea without additional benefit 1
• Don't start allopurinol during a first attack—this is a common error that provides no benefit for acute pain and commits the patient to unnecessary long-term therapy 1
• Don't assume indomethacin is special—any NSAID works equally well 1

Patient Education Points

Explain that this acute treatment addresses pain only, not the underlying uric acid problem. If attacks recur ≥2 times per year, long-term urate-lowering therapy will be necessary. With normal kidney function, this patient is a good candidate for standard-dose allopurinol if future ULT becomes indicated.